Thankfully, 2026 could be a much better year for the Denmark-based drugmaker. Let's consider two tailwinds that could help ...

With just about a week to go until 2026, Novo announced that its new weight loss pill under the brand name Wegovy had been ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

According to pharmaceutical manufacturer Novo Nordisk, the popular weight loss drug Wegovy has been approved in pill form for ...

Danish drugmaker Novo Nordisk (NOV: N) has secured US approval for an oral version of Wegovy (semaglutide), expanding access ...

The primary catalyst for a potential turnaround is the U.S. market introduction of the oral Wegovy tablet (semaglutid 25 mg), scheduled for "early January 2026." Securing FDA approval just before ...

It gives the Danish drugmaker a leg up in the race to market a potent oral medication for shedding pounds as it looks to ...

A daily weight-loss pill will soon be available in the US, after the regulator gave approval to Danish drug company Novo ...

SUMMIT COUNTY — Racing, whether professional or recreational, is all about challenge and achievement. The USA Pro Challenge is an example of an international audience watching professional athletes ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy.